Comparison of CD20 expression in B‐cell lymphoma between newly diagnosed, untreated cases and those after rituximab treatment

Few studies have statistically investigated reduced CD20 expression in B‐cell lymphoma after rituximab therapy and genomic mutation of CD20 associated with reduction. We examined CD20‐positive rate in follicular lymphoma (FL) and diffuse large B‐cell lymphoma (DLBCL) by flow cytometry (FCM) and immu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Sci
Main Authors: Miyoshi, Hiroaki, Arakawa, Fumiko, Sato, Kensaku, Kimura, Yoshizo, Kiyasu, Junichi, Takeuchi, Masanori, Yoshida, Maki, Ichikawa, Ayako, Ishibashi, Yukinao, Nakamura, Yukihiko, Nakashima, Shinji, Niino, Daisuke, Sugita, Yasuo, Ohshima, Koichi
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2012
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7659217/
https://ncbi.nlm.nih.gov/pubmed/22500644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2012.02307.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares